Is Sigachi Laboratories the same as Sigachi Industries?

Sigachi Laboratories Limited (CIN: L24230TG1994PLC018786) and Sigachi Industries Limited are related entities in the Sigachi group. Sigachi Industries Limited was listed on the NSE SME platform in 2021 and is the listed arm of the group. Sigachi Laboratories is a separate, unlisted public limited company. Investors should carefully distinguish between the two entities.

Who are the promoters of Sigachi Laboratories?

Sigachi Laboratories is part of the Sigachi group. Based on available information from the broader Sigachi group (which includes the listed Sigachi Industries), key promoters include Amit Raj Sinha and Hari Mohan Chandra. The group was established in 1989 and has grown to be one of India's prominent MCC manufacturers.

Is Sigachi Laboratories planning an IPO?

As of the knowledge cutoff in 2025, there is no confirmed IPO announcement specifically for Sigachi Laboratories Limited. The related entity, Sigachi Industries Limited, successfully listed on the NSE SME platform in 2021. Any future listing of Sigachi Laboratories would represent an additional capital market event for the Sigachi group.

How do I buy Sigachi Laboratories unlisted shares here?

Raise an enquiry on any company with the quantity you want. Our desk sources the shares and comes back with a firm price and allocation. You accept the allocation, transfer the funds to the desk's published bank account, and once we verify payment the shares are transferred into your demat.

Who am I actually transacting with?

You transact with the desk, not with an anonymous counterparty. When you buy, you buy from the desk; when you sell, you sell to the desk. Shares always route through the desk's own demat account, so there's one accountable party for the whole trade.

How do I pay, and is there a payment gateway?

Payment is by direct bank transfer to Prospire Network Private Limited's published account (CIN U82300UP2025PTC233622), shown to you in-app at the payment step. There is no card gateway and no escrow. Never pay to a personal account or to any account shared over phone, WhatsApp or email — even if the person claims to be from our team.

How long does settlement take?

After you accept an allocation, you have a short window to pay (typically 2 days). Once payment is verified, shares are usually credited to your demat within 2–3 business days, subject to depository timelines and any company-level restrictions. Timeframes are typical, not guaranteed.

There are no separate platform fee lines and no GST on the transfer — the desk's margin is built into the buy/sell price you're quoted. The only statutory add-on on a purchase is stamp duty on the consideration, shown transparently in your cost breakdown.

Is there a minimum ticket size for Sigachi Laboratories?

Minimums vary by company and depend on the lot the desk can source. Raise an enquiry and the desk will confirm the available quantity and the minimum for that name.

What KYC do I need, and do I need a demat account?

You'll share your demat details when you enquire so we can settle directly. Full KYC — PAN and a client-master / demat statement — is required before the transfer step, when shares actually change hands. Yes, you need an active demat account to hold unlisted shares.

Are there lock-ins on unlisted or pre-IPO shares?

Some shares carry statutory or company-imposed lock-ins — for example, a post-listing lock-in on pre-IPO stock — and transfers can be subject to the company's articles or approvals. Where a lock-in applies, we'll flag it before you commit.

How do I sell Sigachi Laboratories shares I already hold?

Raise a sell enquiry with the company, quantity and your target price. The desk confirms a buying price, you transfer your shares into the desk's demat, and once the credit is verified we pay you out by bank transfer to your registered account. The desk never pays out before your shares are received.

Unlisted shares are illiquid, may be hard or impossible to sell, and are not covered by exchange settlement guarantees or investor-protection funds. Pricing is indicative, not live. Read the full Risk Disclosure before you enquire, and invest only what you can afford to lock away.

Sigachi Laboratories Unlisted Share Price | Buy Sigachi Laboratories Pre-IPO Shares — wisefolio

Investment Thesis

Sigachi Laboratories Limited is a niche but well-established manufacturer of Microcrystalline Cellulose (MCC) and pharmaceutical excipients, operating from Telangana and Gujarat. The company benefits from being part of the broader Sigachi group, which has demonstrated market credibility through the successful listing of Sigachi Industries on the NSE SME platform. The pharmaceutical excipients market offers stable, recurring demand driven by India's pharmaceutical manufacturing growth.

Pros

One of India's leading manufacturers of Microcrystalline Cellulose (MCC), a critical pharmaceutical excipient used globally in tablet manufacturing, with established export capabilities
Diversified manufacturing presence across Telangana and Gujarat, providing production scale and supply chain resilience
Strong position in the pharma excipients market, which benefits from the global growth of generic drug manufacturing and India's pharmaceutical industry expansion
Products serve the international pharmaceutical market as well as domestic drug manufacturers, providing geographic revenue diversification

Cons

Note: Sigachi Industries Limited (a related/sister entity) was listed on NSE SME in 2021 — Sigachi Laboratories Limited is a separate unlisted entity, which may cause investor confusion
Pharma excipients is a commoditized business with price pressure from global MCC suppliers including FMC Corporation (USA) and JRS Pharma (Germany)
As an unlisted company, access to public capital markets for growth funding is limited compared to listed pharmaceutical peers

Business Segments

Microcrystalline Cellulose (MCC)

Manufacturing and supply of MCC, the flagship product used as a pharmaceutical excipient in tablet and capsule production

Nutraceuticals & Other Excipients

Supply of nutraceutical ingredients and other pharmaceutical excipients to health supplement manufacturers

Revenue Model

Sigachi Laboratories generates revenue by manufacturing and selling Microcrystalline Cellulose (MCC) and other pharmaceutical excipients to pharmaceutical and nutraceutical companies in India and globally. Revenue is driven by volume of excipients supplied per unit, export pricing, and long-term supply agreements with pharma companies.

Detailed Analysis

Growth outlookExpansion plans, industry tailwinds & headwinds8

Growth Plans

India's pharmaceutical industry growth — India is the world's third-largest drug manufacturer by volume, driving domestic MCC demand

Rising global demand for high-quality pharmaceutical excipients from regulated markets (US, EU) favoring Indian manufacturers

Potential future listing or merger with listed Sigachi Industries to unlock capital market access

Industry Tailwinds

Recent Developments

Sigachi Industries SME IPO

The related listed entity, Sigachi Industries Limited, completed its IPO on the NSE SME platform, raising capital for capacity expansion. The IPO was significantly oversubscribed, reflecting strong investor interest in India's pharmaceutical excipients sector.

2021-11

Comparable Companies

CompanyTypeTickerMkt Cap

Sigachi Industries LimitedListedSIGACHI—

ColorconListedUnlisted (Global)—

Ashland Global HoldingsListedASH (NYSE)—

Sigachi Industries LimitedListed

SIGACHI

Frequently Asked Questions

Sigachi Laboratories Limited is a Hyderabad-based pharmaceutical excipients manufacturer incorporated in 1994, specializing in the production of Microcrystalline Cellulose (MCC) and nutraceutical ingredients. MCC is a widely used excipient in pharmaceutical tablet and capsule manufacturing, acting as a binder, filler, and disintegrant. The company operates manufacturing facilities in Telangana and Gujarat and supplies to domestic and international pharmaceutical companies.

Microcrystalline Cellulose (MCC) is a purified, partially depolymerized cellulose derived from plant sources. It is one of the most widely used pharmaceutical excipients globally, serving as a binder, filler, and disintegrant in tablet and capsule manufacturing. Sigachi Laboratories' focus on MCC positions it at the heart of the pharmaceutical manufacturing supply chain, with applications in both generic drug production and nutraceutical supplements.

About Sigachi Laboratories

Sigachi Laboratories Limited is a Hyderabad-based pharmaceutical excipients company incorporated in 1994 under CIN L24230TG1994PLC018786. The company holds a prominent position in pharma excipients, nutraceuticals, and food ingredients, established as one of India's leading manufacturers of Microcrystalline Cellulose (MCC) since its founding in 1989. Note: The Sigachi group comprises two related entities — Sigachi Industries Limited (listed on NSE: SIGACHI) and Sigachi Laboratories Limited (this unlisted company). Sigachi Laboratories is the earlier entity in the group. Microcrystalline Cellulose (MCC) is the company's flagship product — a critical pharmaceutical excipient used as a binder and filler in tablet manufacturing for generic and specialty pharma companies. The company supplies to pharmaceutical manufacturers across India and internationally. Financially, the company generated revenue of Rs 3.78 crore in FY2025 — reflecting a 1-year revenue CAGR of -13%, indicating near-term revenue contraction. However, Return on Equity improved from 19.4% in FY23 to 29.24% in FY24, suggesting better capital efficiency. The unlisted share price was Rs 43.00 as of May 2025 (face value Rs 10, lot size 4,700 shares). Hyderabad's status as India's pharma hub — home to Dr. Reddy's, Aurobindo, and Sun Pharma — provides Sigachi access to a large domestic customer base. The pharma excipients market is quality-sensitive with high regulatory barriers (US FDA, EU GMP), making Sigachi's 35-year track record a genuine competitive asset.

Key Milestones

Sigachi group founded in 1989 in Hyderabad, beginning MCC manufacturing operations

Common questions about unlisted shares

How do I buy Sigachi Laboratories unlisted shares here?
Raise an enquiry on any company with the quantity you want. Our desk sources the shares and comes back with a firm price and allocation. You accept the allocation, transfer the funds to the desk's published bank account, and once we verify payment the shares are transferred into your demat.
Who am I actually transacting with?
You transact with the desk, not with an anonymous counterparty. When you buy, you buy from the desk; when you sell, you sell to the desk. Shares always route through the desk's own demat account, so there's one accountable party for the whole trade.
How do I pay, and is there a payment gateway?

Sigachi Laboratories Limited

How settlement works

Get price alerts for Sigachi Laboratories Limited

Discuss Sigachi Laboratories

Similar companies

Other ways to invest